Tizanidine Tablet
Product Images NDC 70518-3658

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-3658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Tizanidine 4 mg tablet label by RemedyRepack Inc. The label includes the quantity of 30 tablets and shows the NDC 70518-3658-00. It states the product is prescription only, with manufacturer information as Northstar Rx LLC, Memphis, TN. There is a barcode and a QR code present, along with warnings that the tablets are not interchangeable with capsules and directions to see the package insert.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A pharmacokinetic graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The graph compares four groups: 2 x 4 mg Tizanidine tablets with food, without food, and 2 x 4 mg Tizanidine capsules with and without food. Concentrations peak within the first few hours and decrease to near zero by 12-16 hours post dosing.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph showing improvement in Ashworth score over hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The x-axis represents hours post-dose (0 to 6), and the y-axis represents improvement in Ashworth score from 0 to -5. The 16 mg dose shows the greatest improvement at around 2 hours, followed by 8 mg and then placebo.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A line chart comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo across three time points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The chart shows mean scores with error bars for each group at each time point.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tizanidine hydrochloride, depicting the molecular arrangement including nitrogen and chlorine atoms as part of its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.